Biocon Company Description
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally.
It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab.
It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies.
Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
![Biocon logo](https://img.stockanalysis.com/logos1/NSE/BIOCON.png)
Country | India |
Founded | 1978 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 16,315 |
CEO | Siddharth Mittal |
Contact Details
Address: 20th KM Hosur Road Bengaluru, Karnataka 560100 India | |
Phone | 91 80 2808 2808 |
Website | biocon.com |
Stock Details
Ticker Symbol | BIOCON |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE376G01013 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Peter James Jonathan Bains | Group Chief Executive Officer |
Siddharth Mittal BCom, CA, CPA | MD, Chief Executive Officer and Director |
Mukesh Kamath | Chief Financial Officer |
Arun Gupta | Head of Operations |
Atanu Roy | Group Chief Information Officer |
Saurabh Paliwal | Head of Investor Relations |
Mayank Verma | Company Secretary and Compliance Officer |
Seema Shah Ahuja BA, MBA | Global Head of Communications and Corporate Brand |
Maninder Kapoor Puri | Head of Human Resources |
Paul Vazhayil Thomas | Chief Commercial Officer, U.S. and Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business |